Green Victoria L
Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia.
Clin Obstet Gynecol. 2016 Jun;59(2):419-38. doi: 10.1097/GRF.0000000000000192.
Breast density has emerged as a critical phenotypic marker of increased breast cancer risk. The breast density legislation, passed in multiple states, requires patient notification of the implications of the breast density on breast cancer risk and screening. Supplemental screening may be suggested in the state regulation; however, there are limited data to guide conversations with patients. This article will review the current state of supplemental screening in women with dense breasts and discuss theories of the mechanism of action. Guidance is provided to assist in shared decision making and appropriate patient counseling.
乳腺密度已成为乳腺癌风险增加的关键表型标志物。多个州通过的乳腺密度立法要求告知患者乳腺密度对乳腺癌风险和筛查的影响。州法规中可能建议进行补充筛查;然而,用于指导与患者沟通的数据有限。本文将综述致密乳腺女性补充筛查的现状,并讨论其作用机制的理论。提供指导以协助共同决策和对患者进行适当的咨询。